Inovalon Holdings Inc (INOV):企業の財務・戦略的SWOT分析

◆英語タイトル:Inovalon Holdings Inc (INOV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME48644FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inovalon Holdings Inc (Inovalon), is a technology company that provides cloud-based platforms for healthcare industry. The company designs, develops and distributes software tools to provide healthcare and financial improvement solutions. It offers Inovalon ONE platform and provides data driven solutions for risk score accuracy, data management, medical record audit support, risk score verification processes, and care management. Inovalon’s integrated solutions comprise clinical and quality outcomes; claims and payment integrity; care coordination and healthcare data insights. Inovalon offers quality measurement, reporting and improvement; point-of-care solutions, strategic advisory services and clinical data extraction solutions. The company serves health plans provider organizations, medical device manufacturers, pharmaceutical, and diagnostics companies. It has presence in Arizona, Florida, Georgia, Maryland, and Virginia, the US. Inovalon is headquartered in Bowie, Maryland, the US.

Inovalon Holdings Inc Key Recent Developments

Mar 31,2021: Inovalon data powers new insights on diverse healthcare population
Feb 04,2021: Inovalon Holdings, Inc. (INOV) CEO Keith Dunleavy on Q4 2020 Results – Earnings Call Transcript
Feb 03,2021: Inovalon reports fourth quarter and full year 2020 results
Jan 20,2021: Inovalon Announces Fourth Quarter and Full Year 2020 Earnings Conference Call
Jan 11,2021: Inovalon reports preliminary fourth quarter 2020 results

This comprehensive SWOT profile of Inovalon Holdings Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Inovalon Holdings Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Inovalon Holdings Inc – Key Information
Inovalon Holdings Inc – Overview
Inovalon Holdings Inc – Key Employees
Inovalon Holdings Inc – Key Employee Biographies
Inovalon Holdings Inc – Key Operational Heads
Inovalon Holdings Inc – Major Products and Services
Inovalon Holdings Inc – History
Inovalon Holdings Inc – Company Statement
Inovalon Holdings Inc – Locations And Subsidiaries
Inovalon Holdings Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Inovalon Holdings Inc – Business Description
Inovalon Holdings Inc – Corporate Strategy
Inovalon Holdings Inc – SWOT Analysis
SWOT Analysis – Overview
Inovalon Holdings Inc – Strengths
Inovalon Holdings Inc – Weaknesses
Inovalon Holdings Inc – Opportunities
Inovalon Holdings Inc – Threats
Inovalon Holdings Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Inovalon Holdings Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Inovalon Holdings Inc, Key Information
Inovalon Holdings Inc, Key Ratios
Inovalon Holdings Inc, Share Data
Inovalon Holdings Inc, Major Products and Services
Inovalon Holdings Inc, History
Inovalon Holdings Inc, Key Employees
Inovalon Holdings Inc, Key Employee Biographies
Inovalon Holdings Inc, Key Operational Heads
Inovalon Holdings Inc, Other Locations
Inovalon Holdings Inc, Subsidiaries
Inovalon Holdings Inc, Key Competitors
Inovalon Holdings Inc, SWOT Analysis
Inovalon Holdings Inc, Ratios based on current share price
Inovalon Holdings Inc, Annual Ratios
Inovalon Holdings Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Inovalon Holdings Inc (INOV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Future Plc (FUTR):企業の財務・戦略的SWOT分析
    Summary Future Plc (Future) is a media company that offers media and digital business solutions various customers. The company offers its services in various areas such as technology, photography, creative and design, games, advertising and film and music. It provides licensing and syndication, expo …
  • Service Corporation International (SCI):企業の財務・戦略的SWOT分析
    Service Corporation International (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Pentair plc:企業の戦略・SWOT・財務分析
    Pentair plc - Strategy, SWOT and Corporate Finance Report Summary Pentair plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Zhejiang Medicine Co Ltd (600216):企業の財務・戦略的SWOT分析
    Zhejiang Medicine Co Ltd (600216) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Zebra Technologies Corporation:企業の戦略・SWOT・財務情報
    Zebra Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Zebra Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • GridPoint, Inc.-エネルギー分野:企業M&A・提携分析
    Summary GridPoint, Inc. (Gridpoint), a subsidiary of Twenty First Century Utilities LLC, is a provider of data-driven energy management systems. The company offers a wide range of energy management hardware including control, equipment-level sub-metering and advanced monitoring devices such as contr …
  • Cepheid:医療機器:M&Aディール及び事業提携情報
    Summary Cepheid, a subsidiary of Danaher Corporation, is a molecular diagnostic company that develops, manufactures and markets molecular systems and tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious d …
  • Viridian Energy Supply Ltd:企業の戦略的SWOT分析
    Viridian Energy Supply Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Selex Gruppo Commerciale S.p.A.:企業の戦略・SWOT・財務情報
    Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BaroFold Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BaroFold Inc (BaroFold) is a biotechnology company that provides protein herapeutics for bio-pharmaceutical companies, research institutions, and government agencies. The company applies its Pressure Enabled Protein Manufacturing (PreEMT) technology that improves the tolerability, efficacy a …
  • GC Pharma (006280):製薬・医療:M&Aディール及び事業提携情報
    Summary GC Pharma(GC Pharma) formerly known as Green Cross Corp, a subsidiary of Green Cross Holdings Corp provides plasma protein therapeutics and vaccines. The company develops, manufactures and markets a wide product portfolio comprising plasma derivatives including albumin, immunoglobulin, and a …
  • Elizabeth Arden, Inc. (RDEN):企業の財務・戦略的SWOT分析
    Elizabeth Arden, Inc. (RDEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sun BioPharma Inc (SNBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • Lantern Pharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Lantern Pharma Inc (Lantern Pharma) is a drug development company that discovers and develops therapies for various cancer types. The company’s pipeline products include Irofulven-1, an anti-tumor agent is developed to fight against multi-drug resistant cancers. Its Irofulven-1 is used for t …
  • Pentair Plc (PNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Pentair Plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water treatment systems and high-performance products and solutions for filtration, separation and fluid process management. Its product portfolio includes point-of-entry and point-of-use filtr …
  • Barratt Developments Plc:企業の戦略・SWOT・財務情報
    Barratt Developments Plc - Strategy, SWOT and Corporate Finance Report Summary Barratt Developments Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hanger, Inc.-医療機器分野:企業M&A・提携分析
    Summary Hanger, Inc. (Hanger) formerly Hanger Orthopedic Group, Inc., is a health care and medical device company. The company along with its subsidiaries offers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions. Hanger is one of the largest owner …
  • Xencor Inc (XNCR):企業の財務・戦略的SWOT分析
    Summary Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company. It develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the t …
  • Tobu Railway Co Ltd:企業の戦略・SWOT・財務情報
    Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China Haisheng Juice Holdings Co Ltd:企業の戦略・SWOT・財務分析
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆